Related Experiment Video
Updated: Jun 17, 2026

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.
James J Lee1, Mitsuteru Natsuizaka, Shinya Ohashi
1Gastroenterology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Carcinogenesis
|January 1, 2010
Summary
Prostaglandin E synthase (PTGES) is a novel hypoxia-inducible factor-1alpha target gene identified in esophageal squamous cell carcinoma (ESCC). This finding reveals PTGES
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hypoxia-inducible factors (HIFs), particularly HIF-1alpha, play a significant role in tumor biology.
- Identifying HIF target genes within the esophageal tumor microenvironment is crucial for understanding tumor progression.
Purpose of the Study:
- To identify novel HIF target genes in the esophageal tumor microenvironment.
- To investigate the role of prostaglandin E synthase (PTGES) in esophageal squamous cell carcinoma (ESCC) under hypoxic conditions.
Main Methods:
- Gene expression profiling of hypoxia-exposed esophageal epithelial cells (EPC2-hTERT) compared to ESCC gene signatures.
- Validation of PTGES as a HIF-1alpha target gene using hypoxia, cobalt chloride, and dominant-negative HIF-1alpha.
- Assessment of Prostaglandin E2 (PGE2) biosynthesis and PTGES expression in ESCC cells and primary tumors.
Main Results:
- Prostaglandin E synthase (PTGES) was identified as a novel HIF-1alpha target gene, upregulated in ESCC and hypoxia-exposed cells.
- PTGES induction was dependent on HIF-1alpha stabilization and regulated at both mRNA and protein levels.
- Hypoxia stimulated PGE2 production in a HIF-1alpha-dependent manner, and PTGES was frequently overexpressed in ESCC.
Conclusions:
- PTGES is a novel HIF-1alpha target gene involved in prostaglandin E biosynthesis within the hypoxic esophageal tumor microenvironment.
- The COX-2-PTGES axis is activated in ESCC, suggesting its potential role in tumor progression.
- Findings have implications for understanding and potentially targeting hypoxic microenvironments in various tumor types, especially squamous cell carcinomas.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...